A new study from Norway found a 42% lower risk of developing MS among women with greater dietary vitamin D intake, ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...

A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

The current study shows that the Epstein–Barr virus can interfere with the normal control of B cells. One viral protein ...

The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...

Researchers at McMaster University in Hamilton are observing people with multiple sclerosis as they exercise while they play ...